Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GRZEGORZ S NOWAKOWSKI

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1629040076
CMS profile
208930
Location
ROCHESTER, MN

General Payments · PY2018–2024

$189,215.57

  • Reported across 141 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$58,152.86

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
F. Hoffmann-La Roche AG $19,534.29 6
Incyte Corporation $13,597.08 5
Acerta Pharma LLC $6,389.11 6
ABBVIE INC. $4,950.00 2
Kite Pharma, Inc. $4,020.00 1
Genmab U.S., Inc. $2,663.37 2
Genentech USA, Inc. $2,280.00 1
Regeneron Pharmaceuticals, Inc. $1,854.00 1
E.R. Squibb & Sons, L.L.C. $1,493.01 3
Amgen Inc. $1,372.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $23,378.00 12
PY2019 $7,043.15 36
PY2020 $40,059.27 27
PY2021 $18,006.32 6
PY2022 $20,775.77 18
PY2023 $21,800.20 14
PY2024 $58,152.86 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $4,400.00 03/12/2024 Consulting Fee Undisputed 01/23/2026 1105135784 CMS
ABBVIE INC. $550.00 04/02/2024 Consulting Fee Undisputed 01/23/2026 1105135786 CMS
Amgen Inc. $1,372.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1111663565 CMS
AstraZeneca Pharmaceuticals LP $8.06 02/08/2024 Food and Beverage Undisputed 01/23/2026 1104690002 CMS
AstraZeneca Pharmaceuticals LP $15.33 02/12/2024 Food and Beverage Undisputed 01/23/2026 1104353522 CMS
AstraZeneca Pharmaceuticals LP $106.76 02/12/2024 Food and Beverage Undisputed 01/23/2026 1105401013 CMS
AstraZeneca Pharmaceuticals LP $25.12 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104198983 CMS
AstraZeneca Pharmaceuticals LP $68.84 03/12/2024 Travel and Lodging Undisputed 01/23/2026 1104550254 CMS
AstraZeneca Pharmaceuticals LP $6,165.00 03/12/2024 Consulting Fee Undisputed 01/23/2026 1104692578 CMS
E.R. Squibb & Sons, L.L.C. $1,384.00 06/04/2024 Consulting Fee Undisputed 01/23/2026 1101756460 CMS
E.R. Squibb & Sons, L.L.C. $30.01 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101756583 CMS
E.R. Squibb & Sons, L.L.C. $79.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1101756587 CMS
F. Hoffmann-La Roche AG $8,360.00 04/19/2024 Consulting Fee Undisputed 01/23/2026 1133016972 CMS
F. Hoffmann-La Roche AG $272.12 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1133016976 CMS
F. Hoffmann-La Roche AG $81.36 04/19/2024 Food and Beverage Undisputed 01/23/2026 1133016980 CMS
F. Hoffmann-La Roche AG $8,479.65 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1133016984 CMS
F. Hoffmann-La Roche AG $61.16 04/19/2024 Travel and Lodging Undisputed 01/23/2026 1133016988 CMS
F. Hoffmann-La Roche AG $2,280.00 10/29/2024 Consulting Fee Undisputed 01/23/2026 1133016992 CMS
Genentech USA, Inc. $2,280.00 11/11/2024 Consulting Fee Undisputed 01/23/2026 1133016968 CMS
Genmab U.S., Inc. $2,437.50 07/15/2024 Consulting Fee Undisputed 01/23/2026 1126826880 CMS
Genmab U.S., Inc. $225.87 07/15/2024 Food and Beverage Undisputed 01/23/2026 1126826882 CMS
Incyte Corporation $124.56 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1141170803 CMS
Incyte Corporation $687.25 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1141170805 CMS
Incyte Corporation $64.77 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1141170865 CMS
Incyte Corporation $48.00 10/09/2024 Travel and Lodging Undisputed 01/23/2026 1141170867 CMS
Incyte Corporation $12,672.50 10/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1141262401 CMS
Kite Pharma, Inc. $4,020.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 1128612691 CMS
Regeneron Pharmaceuticals, Inc. $1,854.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1114403051 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.